Cleared Special

SiteSeal SV (K210681) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K210681 · Ensite Vascular · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2021
Decision
29d
Days
Class 2
Risk

K210681 is an FDA 510(k) clearance for the SiteSeal SV. Classified as Clamp, Vascular (product code DXC), Class II - Special Controls.

Submitted by Ensite Vascular (Olathe, US). The FDA issued a Cleared decision on April 6, 2021 after a review of 29 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4450 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Ensite Vascular devices

Submission Details

510(k) Number K210681 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 08, 2021
Decision Date April 06, 2021
Days to Decision 29 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
96d faster than avg
Panel avg: 125d · This submission: 29d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DXC Clamp, Vascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4450
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Brosseau Consulting, LLC
Bryan Brosseau

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DXC Clamp, Vascular

All 39
Devices cleared under the same product code (DXC) and FDA review panel - the closest regulatory comparables to K210681.
Radial Artery Compression Tourniquets
K222182 · Beijing Demax Medical Technology Co.,Ltd · Jan 2023
GEM Biover Microvascular Clamps
K221843 · Synovis Micro Companies Alliance, Inc. · Sep 2022
TR BAND Radial Compression Device
K213531 · Terumo Medical Corporation · Dec 2021
MI DeTACH
K210006 · Biorep Technologies, Inc. · Mar 2021
V. Mueller Cosgrove Flex Clamps, Model Number-CV1033, CV1061, CV1133, CV1161, CV1186
K210324 · Carefusion 2200, Inc. · Mar 2021
VIOLA
K203307 · Vascular Graft Solutions, Ltd. · Feb 2021